Jamjoom Pharma, a leading Saudi pharmaceutical healthcare company in the Middle East and Africa (MEA), has signed a Memorandum of Understanding (MoU) with the General Administration of Pharmaceutical Care at the Ministry of Health Saudi Arabia, aiming to support the development of healthcare and pharmaceutical professionals through training programmes and educational initiatives, contributing to enhancing the quality of healthcare services and achieving the objectives of Saudi Vision 2030.
The agreement comes as part of Jamjoom Pharma’s broader strategy to strengthen its role as an active national partner in advancing the healthcare sector by investing in healthcare and pharmaceutical talent development, supporting community awareness programmes, and expanding collaboration with government health entities.
Under the MoU signed between Jamjoom Pharma and the General Administration of Pharmaceutical Care at the Ministry of Health Saudi Arabia, the two parties will collaborate on implementing developmental programmes across administrative, technical, and specialised fields, in addition to designing and developing curriculums in line with the professional global standards, and organising workshops, seminars, and forums related to pharmaceutical training and development.
The collaboration will also include assessing the training needs of HCPs, providing professional consultations, evaluating the impact of training programmes, and exchanging expertise in professional development fields.
The MoU was signed by Ahmed Samir Al Khouly, General Manager at Jamjoom Pharma Saudi Arabia, and Mohammed Alshennawi, General Director of the General Administration of Pharmaceutical Care at the Ministry of Health, Kingdom of Saudi Arabia (KSA).
